Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2

Explore clinical trials studying Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2 trial results

Completed

ATHENA: Natural History of Disease Study in Alport Syndrome Patients

NCT02136862

Conditions: Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2, Collagen Diseases, Congenital Abnormalities, +12 more
Locations: San Diego, California, United States

Chicago, Illinois, United States

Minneapolis, Minnesota, United States

St Louis, Missouri, United States

View all 15 locations

View Trial Details

Collagen Diseases (1)
Congenital Abnormalities (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Connective Tissue Diseases (1)
Female Urogenital Diseases (1)
Female Urogenital Diseases and Pregnancy Complications (1)
Kidney Diseases (1)
Male Urogenital Diseases (1)

Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2

Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2 trial results

ATHENA: Natural History of Disease Study in Alport Syndrome Patients

Related conditions